WO2013087405A3 - Capsules de libération, procédé de fabrication et utilisations correspondants - Google Patents

Capsules de libération, procédé de fabrication et utilisations correspondants Download PDF

Info

Publication number
WO2013087405A3
WO2013087405A3 PCT/EP2012/073687 EP2012073687W WO2013087405A3 WO 2013087405 A3 WO2013087405 A3 WO 2013087405A3 EP 2012073687 W EP2012073687 W EP 2012073687W WO 2013087405 A3 WO2013087405 A3 WO 2013087405A3
Authority
WO
WIPO (PCT)
Prior art keywords
release capsules
manufacture
relates
capsules
products
Prior art date
Application number
PCT/EP2012/073687
Other languages
English (en)
Other versions
WO2013087405A2 (fr
Inventor
Robert Wengeler
Jing Dreher
Andrew FULL
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Priority to US14/364,938 priority Critical patent/US20140335173A1/en
Publication of WO2013087405A2 publication Critical patent/WO2013087405A2/fr
Publication of WO2013087405A3 publication Critical patent/WO2013087405A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/652—The particulate/core comprising organic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

La présente invention concerne de nouvelles capsules de libération, notamment conçues pour protéger des substances sensibles à l'humidité, en particulier des compositions pour produire du dioxyde de chlore. L'invention concerne également des procédés de fabrication de telles capsules de libération, des utilisations de telles capsules de libération, ainsi que des produits comprenant celles-ci.
PCT/EP2012/073687 2011-12-13 2012-11-27 Capsules de libération, procédé de fabrication et utilisations correspondants WO2013087405A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/364,938 US20140335173A1 (en) 2011-12-13 2012-11-27 Release capsules, manufacture and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161569800P 2011-12-13 2011-12-13
EP11193201.8 2011-12-13
US61/569,800 2011-12-13
EP11193201 2011-12-13

Publications (2)

Publication Number Publication Date
WO2013087405A2 WO2013087405A2 (fr) 2013-06-20
WO2013087405A3 true WO2013087405A3 (fr) 2014-03-20

Family

ID=48613301

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/073687 WO2013087405A2 (fr) 2011-12-13 2012-11-27 Capsules de libération, procédé de fabrication et utilisations correspondants

Country Status (2)

Country Link
US (1) US20140335173A1 (fr)
WO (1) WO2013087405A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102069856B1 (ko) * 2014-09-19 2020-01-23 더 홍콩 유니버시티 오브 사이언스 앤드 테크놀러지 표면의 장기 살균을 위한 항균 코팅
CN113197221B (zh) * 2021-05-14 2021-12-31 天津清科环保科技有限公司 溶胶-凝胶缓释二氧化氯凝胶及制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01003507A (es) * 1998-10-08 2002-06-26 Hampar L Karagoezian Antimicrobiano sinergico, preparaciones dermatologicas y oftalmicas que contienen clorito y peroxido de hidrogeno.
WO2008069561A1 (fr) * 2006-12-05 2008-06-12 Seoul National University Industry Foundation Vnanocapsule creuse en oxyde métallique et procédé d'élaboration
US20100016443A1 (en) * 2007-02-01 2010-01-21 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
WO2011097224A1 (fr) * 2010-02-02 2011-08-11 Basf Se Générateur de dioxyde de chlore encapsulé
WO2011131644A1 (fr) * 2010-04-20 2011-10-27 Basf Se Capsule comprenant un ingrédient actif

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853202A (en) 1987-09-08 1989-08-01 Engelhard Corporation Large-pored crystalline titanium molecular sieve zeolites
ES2197513T3 (es) 1997-11-07 2004-01-01 Engelhard Corporation Procedimiento y dispositivo para la produccion de una solucion acuosa que contiene dioxido de cloro.
US7382514B2 (en) * 2002-02-11 2008-06-03 Sipix Imaging, Inc. Core-shell particles for electrophoretic display
US8017152B2 (en) * 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
US8673297B2 (en) 2006-02-28 2014-03-18 Basf Corporation Chlorine dioxide based cleaner/sanitizer
US8088300B2 (en) 2006-06-21 2012-01-03 Basf Corporation Stabilized composition for producing chlorine dioxide

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01003507A (es) * 1998-10-08 2002-06-26 Hampar L Karagoezian Antimicrobiano sinergico, preparaciones dermatologicas y oftalmicas que contienen clorito y peroxido de hidrogeno.
WO2008069561A1 (fr) * 2006-12-05 2008-06-12 Seoul National University Industry Foundation Vnanocapsule creuse en oxyde métallique et procédé d'élaboration
US20100016443A1 (en) * 2007-02-01 2010-01-21 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
WO2011097224A1 (fr) * 2010-02-02 2011-08-11 Basf Se Générateur de dioxyde de chlore encapsulé
WO2011131644A1 (fr) * 2010-04-20 2011-10-27 Basf Se Capsule comprenant un ingrédient actif

Also Published As

Publication number Publication date
US20140335173A1 (en) 2014-11-13
WO2013087405A2 (fr) 2013-06-20

Similar Documents

Publication Publication Date Title
ZA201403929B (en) Microcapsules, a process of making such microcapsules and composition utilising such microcapsules
EP2663593B8 (fr) Compositions polymères, procédé de production et articles formées à partir de ces dernières
EP2925788A4 (fr) Procédés et appareil de production de nanocellulose et compositions et produits obtenus à partir de celle-ci
WO2011138281A3 (fr) Procédé de production de dithiine-tétracarboxy-diimides
EP2812298A4 (fr) Procédé amélioré de fabrication de 2,3,3,3-tétrafluoropropène
EP2251038A4 (fr) Dispersion solide, compositions pharmaceutiques comprenant celle-ci, et procédés de production associés
WO2012156998A3 (fr) Mirabegron amorphe et procédés de préparation de formes cristallines de mirabegron
HUE037747T2 (hu) Nanostrukturált aprepirant készítmények, eljárások azok elõállítására és az azokat tartalmazó gyógyászati készítmények
WO2011157722A3 (fr) Composition contenant de l'ivabradine solide
WO2013181586A3 (fr) Méthodes associées au bevacizumab
WO2013166211A3 (fr) Identification de variants d'isoprène synthase présentant des propriétés améliorées pour la production d'isoprène
WO2010102778A3 (fr) 3-aminoisoxazolopyridines substituées en tant que modulateurs de kcnq 2/3
WO2013134534A3 (fr) Formes à l'état solide de cabazitaxel et procédés pour les préparer
WO2013164839A8 (fr) Forme amorphe d'apixaban, son procédé de préparation et compositions de celle-ci
ZA201501372B (en) Production of soluble protein products from hemp ("h701")
WO2014100000A8 (fr) Composants polyamide thermoplastiques, compositions et procédés pour leur fabrication et leur installation
EP2663592B8 (fr) Compositions polymères, procédé de production et articles formés à partir de ces compositions polymères
WO2014068586A3 (fr) Compositions orales solides de tolvaptan
EP2540762A4 (fr) Composition pour matériaux optiques, son procédé de fabrication et matériaux optiques fabriqués à partir de la composition
WO2013181575A3 (fr) Méthodes associées au denosumab
PT2526047T (pt) Processo para a produção de dióxido de cloro
WO2014048776A3 (fr) Isocyanates émulsionnables dans l'eau à brillance améliorée
WO2012137227A3 (fr) Formes solides de composés antirétroviraux, procédé de préparation correspondant et composition pharmaceutique de ces composés
WO2013190274A3 (fr) Compositions
WO2013168176A3 (fr) Procédé pour la préparation de fosaprépitant et sel de celui-ci

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12791190

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2012791190

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12791190

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14364938

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 12791190

Country of ref document: EP

Kind code of ref document: A2